These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17050502)

  • 1. Tolerability to 1-year treatment with once-daily molsidomine in patients with stable angina.
    Messin R; Bruhwyler J; Dubois C; Famaey JP; Géczy J
    Adv Ther; 2006; 23(4):601-14. PubMed ID: 17050502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: double-blind and open-label studies.
    Messin R; Cerreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Adv Ther; 2006; 23(1):107-30. PubMed ID: 16644612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative short-term effect of once-daily molsidomine on chronic angina in general practitioners' versus cardiologists' coronary patient populations.
    Messin R
    Adv Ther; 2014 Jan; 31(1):91-106. PubMed ID: 24307221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of once-daily molsidomine in coronary patients from two distinct European ethnicities.
    Messin R; Dubois C; Famaey JP
    Adv Ther; 2008 Nov; 25(11):1200-14. PubMed ID: 19002405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
    Alpert JS; Kobrin I; DeQuattro V; Friedman R; Shepherd A; Fenster PE; Thadani U
    Am J Cardiol; 1997 Apr; 79(8):1025-30. PubMed ID: 9114758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
    Witchitz S; Kolsky H; Moisson P; Valette H
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with the NO-donor molsidomine reduces circulating ICAM-1 levels in patients with stable angina.
    Van Hove C; Carreer-Bruhwyler F; Géczy J; Herman AG
    Atherosclerosis; 2005 Jun; 180(2):399-405. PubMed ID: 15910868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial.
    Messin R; Karpov Y; Baikova N; Bruhwyler J; Monseu MJ; Guns C; Géczy J
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):271-6. PubMed ID: 9475269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.
    Frishman WH; Bittar N; Glasser S; Habib G; Smith W; Pordy R
    Clin Cardiol; 1998 Jul; 21(7):483-90. PubMed ID: 9669057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic stable angina: follow-up study with nifedipine gastrointestinal therapeutic system. SENIOR Study Group].
    Fuertes García A; Sagués Cabarro F; González Juanatey JR; de Lombera Romero F; Luengo Fernández E; Palencia Pérez MA; Vargas García R; Wilke Delgado M
    Rev Esp Cardiol; 2000 Jan; 53(1):35-42. PubMed ID: 10701321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
    De Backer GG; Derese A
    Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
    Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
    Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
    Rudolph W; Dirschinger J
    Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world Evidence for the Antianginal Efficacy of Trimetazidine from the Russian Observational CHOICE-2 Study.
    Glezer M;
    Adv Ther; 2017 Apr; 34(4):915-924. PubMed ID: 28220388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.